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Abstract:   
Y95B8A.12 gene of C. elegans encodes RhoGEF domain, which is a novel module in the Guanine nucleotide exchange factors 
(GEFs). Alternative splicing increases transcriptome and proteome diversification. Y95B8A.12 gene has two reported alternatively 
spliced transcripts by the C. elegans genome sequencing consortium. In the work presented here, we report the presence of four new 
spliced transcripts of Y95B8A.12 arising as a result of alternative splicing in the pre-mRNA encoded by Y95B8A.12 gene. Our 
methodology involved the use of various gene or exon finding programmes and several other bioinformatics tools followed by 
experimental validation. We have also studied alternative splicing pattern in RhoGEF domain encoding orthologues gene from C. 
briggsae  and have obtained very similar results. These new unreported spliced transcripts, which were not detected through 
conventional approaches, not only point towards the extent of alternative splicing in C. elegans genes but also emphasize towards 
the need of analyzing genome data using a combinations of bioinformatics tools to delineate all possible gene products. 
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Background:  
The guanine nucleotide exchange factors for the Rho GTPases 
(RhoGEFs) are a large family of proteins that share a dual 
structural motif designated the DH/PH domain. RhoGEFs are 
regulators of the Rho proteins [1] that act as molecular 
switches; cycling between inactive (GDP-bound) and active 
(GTP-bound) states. [2] The interaction of Rho with residues 
within the DH domain enhances the exchange of GDP for 
GTP and thus converts Rho into the biologically active form. 
Thus, the intracellular ratio of the GTP/GDP-bound forms of 
Rho proteins determines the activation of signal transduction 
pathways regulating the spatial and temporal reorganization 
of cytoskeletal architecture. [3] Members of the Rho 
subfamily of Ras-like monomeric GTPases,
  including Rho, 
Rac and Cdc42, are involved in a broad range
 of functions 
including gene transcription, cell cycle progression,
  cell 
polarity and most notably regulation of the actin cytoskeleton
 
and cell morphology. [4] 
 
RhoGEF family is a widespread family found commonly in 
almost all organisms like Humans, Mouse, and Drosophila, C. 
elegans  etc. In C. elegans this family consists of a large 
number of members and here the number of RhoGEF and 
RhoGAP regulators of Rho GTPases significantly
 exceeds the 
number of Rho family GTPases. These regulators likely 
provide the signaling
  specificity and spatial-temporal 
regulation required by the
 broadly expressed and functionally 
important Rho family GTPases.
  Alternative splicing has 
recently emerged as a major mechanism
 of generating protein 
diversity in higher eukaryotes including nematodes 
Caenorhabditis elegans. [5, 6, 7] Several cases of alternative 
RNA splicing have been found in various RhoGEF domain 
containing and Rho related proteins in various organisms [8, 
9] and even in other RhoGEF domain containing genes of C. 
elegans. [10] Currently, most efficient methods use expressed
 
sequence tags or microarray analysis for efficient detection
 of 
alternative splicing. [11-14] However, it is difficult to detect
 
all alternative splice events with them because of their 
inherent
 limitations as discussed. [15] 
 
Recently, we successfully demonstrated identification of 
novel transcripts using a bioinformatics methodology 
involving both computational and experimental analysis in C. 
elegans.  [15] Genefinder prediction by the C. elegans 
sequencing consortium of genomic sequence of Y95B8A.12 
has reported two spliced transcripts Y95B8A.12a and 
Y95B8A.12b that arise as a result of alternative splicing 
alternative splicing of pre-mRNA in the intronic region 
between exon 2 and exon 3 of Y95B8A.12. Detailed analysis 
of Y95B8A.12 gene using a wide array of bioinformatics 
tools and programmes like gene/exon/ORF finding tools, 
BLAST analysis, sequence alignment programmes and many 
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alternatively spliced transcripts Y95B8A.12c, Y95B8A.12d, 
Y95B8A.12e and Y95B8A.12f. These were subsequently 
confirmed by the presence of different transcripts by RT-PCR 
using gene specific primers and RNA isolated from mixed 
population of C. elegans.  
 
Methodology:  
Nematode 
The wild-type C. elegans strain, N2 (var. Bristol), and the
 
attenuated  E. coli strain was used as a food source in all 
experiments as described essentially in. [16] All nematodes 
were cultured at 20°C on
  standard NGM agar (0.3 percent 
NaCl, 0.25 percent peptone, 5 mg per ml cholesterol,
 1 mM 
CaCl2, 1 mM MgSO4, 1.7 percent agar) seeded with live 
Escherichia
 coli (OP50). 
 
Chemicals 
RevertAid™ M-MuLV Reverse Transcriptase and oligo 
(dT)18
  primer were purchased from Fermentas, Hanover, 
(USA),  Taq DNA Polymerase and PCR-Buffer were 
purchased from Bangalore Genie Pvt. Ltd., India. dNTP Mix 
(2.5 mM each) and 1kb DNA ladder was purchased from MBI 
Fermentas, USA. All other chemicals used in the experiments 
were of molecular biology grade. 
 
Primers used 
The following oligonucleotides primers were custom 
synthesized from MWG Biotech, Pvt. Ltd., India.  
(1) F1: 5' GCAGTTGTTCACCCCGTTGATTAG 3' 
(2) F2: 5' ACATACGAGGAAATCAATTGATTAAGCC 3' 
(3) F3: 5' CGGCAAGACTTCAGGATCGATGGAG 3' 
(4) R1: 5' TCCAGCTCATCATCCTCAATCTC 3' 
(5) R1: 5' AATAATCTCCCTCCGTTTTGCTCTGCCC 3' 
 
Total RNA Isolation 
Total RNA was isolated from mixed-stage nematodes using 
the method described earlier. [17] Finally, total RNA was 
dissolved in diethyl pyrocarbonate-treated distilled water. The 
yield of RNA was determined spectrophotometrically,
 and the 
quality of the RNA was checked by gel electrophoresis. The 
resulting RNA was used for RT- PCR. 
 
Reverse transcriptase (RT)-PCR 
Computationally predicted transcripts encoding alternatively 
spliced exons were validated using RT-PCR. C. elegans total 
RNA (2 micro gram) was primed with oligo (dT)18 and single-
stranded cDNA was synthesized using the Revert Aid™ 
Reverse Transcriptase at 42 degree C for 60 min. (total vol. 
20 micro liter). The target sequences were PCR amplified in 
25 micro liter reaction volume. The
 program consisted of an 
initial denaturation step at 95 degree C
 for 5 min, followed by 
30 cycles at 94 degree C for 1 min, 58 degree C
 for 1 min, and 
72 degree C for 1 min. The program ended with a
  final 
elongation step at 72 degree C for 10 min.
 RT-PCR product (8 
micro liter) obtained after 30 cycles were electrophoretically 
separated on a 2 percent agarose gel, stained with ethidium-
bromide and photographed on a UV transilluminator. 
Semi nested PCR 
For further confirmation of results obtained after first round 
of PCR (for the presence of predicted spliced transcripts), 
semi nested PCR was performed. Here, after the first PCR 
amplification (as detailed above) the resulting RT-PCR 
product (2  micro liter) was used as a template for further 
amplification by PCR using the same forward but a new 
reverse primer (placed just internal to the reverse primer used 
in first
 PCR) specific for the same exon (as used in first PCR). 
The resulting semi nested PCR product (10 micro liter) was 
then subjected to electrophoresis on a 1 percent (weight by 
volume) agarose gel, stained with ethidium bromide and 
photographed on UV transilluminator.  
 
Tools used for Computational and Bioinformatic analysis 
Sequences of the RhoGEF domain encoding gene Y95B8A.12 
was downloaded form the NCBI nucleotide database at 
http://www.ncbi.nlm.nih.gov/entrez. Various other gene/exon 
finding tools and other bioinformatics programmes used were 
same as described in [15, 18] and as below:  
 
The Genescan program [19], predicts complete, partial and 
multiple genes on both DNA strands. It can be used to 
identify introns, exons, promoter sites, polyA signals, etc. It is 
available at http://genes.mit.edu/GENSCAN.html 
 
The  FEX (Find Exon) [20, 21], program initially predicts 
internal exons by linear discriminant function, evaluating 
open reading frames flanked by GT and AG base pairs (the 5' 
and 3' ends of typical introns). It is available at 
http://www.softberry.com/berry.phtml 
 
Twinscan [22] makes predictions by combing the information 
from predicted coding regions and splice sites with 
conserservation measurements between the target sequence 
and sequences from a closely related genome. It is available at 
http://genes.cse.wustl.edu/ 
 
FGENESH [23] is also based on the Hidden Markov Model 
(HMM). It is available at http://sun1.softberry.com under 
section products. 
 
Splice Predictor implements Bayesian models for splice site 
prediction [24] is available at 
http://bioinformatics.iastate.edu/cgi-bin/sp.cgi 
 
The NetGene2 server [25] is a service producing neural 
network predictions of splice sites in human, C. elegans and 
A. thaliana genomic sequences. The method is based on a 
hybrid of a Markov model and neural networks where 
parameters of the Markov model are learned by neural 
networks. It is located at 
http://www.cbs.dtu.dk:80/services/NetGene2 
 
Results and Discussion: 
Computational prediction of new alternative splice 
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Our analysis comprised use of a combination of various 
bioinformatics tools like gene finding programmes, exon 
predicting tools, ORF finders, blast searches and several other 
tools as detailed in our previous study. [15] Thus 
bioinformatics analysis of the  approximately 19kb of 
untranslated region between the predicted initiation codon of 
the gene Y95B8A.2 (lying immediately upstream of 
Y95B8A.12a) and the initiation codon of Y95B8A.12a, 
predicted the possibility of 2 new potential spliced exons. 
These new exons were predicted to encode 15 to 21 amino 
acids and had methionine as the initiation codon and each 
potentially able to splice into exon 2 as shown (Figure 1 and 
Tables 1 and 2 (under supplementary material)). As there 
were two already reported spliced transcripts and 
computational analysis had predicted two new N-terminal 
exons, so by combining the results we were able to predict 
four new alternatively spliced transcripts of the gene 
Y95B8A.12 namely Y95B8A.12c, Y95B8A.12d, 
Y95B8A.12e and Y95B8A.12f. All these new spliced 
transcripts arise due to alternative splicing of Y95B8A.12 pre-
mRNA in 5' untranslated region. In Y95B8A.12c a new N-
terminal formed by 65 bp exon, splices with the second exon 
of the control transcript Y95B8A.12a and lies 7719 bp 
upstream of the first exon of the control Y95B8A.12a. 
Similarly, in Y95B8A.12d a new N-terminal exon of 47 bp, 
splices with the second exon of the control transcript and lies 
7422 bp upstream from the first exon of the control 
Y95B8A.12a. (Figure 1 and Table 1 (under supplementary 
material)). So now we have a total of 6 spliced transcripts of 
C. elegans gene Y95B8A.12 (Y95B8A.12c, Y95B8A.12d, 
Y95B8A.12e and Y95B8A.12f) which splice together in the 
pattern as shown (Figure 1 and Tables 1 and 2 (in 
supplementary material)). Since all these transcripts arise 
because of alternative splicing of non-coding exons, it may 
add further complexity to Y95B8A.12 gene regulation and 
working mechanism. 
 
Following the computational predictions of new spliced 
transcripts, we searched the Yuji Kohara’s C. elegans EST 
database to look for putative EST or cDNA support for 
possible occurrence of these new exons or transcripts. A 
search of Yuji Kohara’s C. elegans EST database for EST 
match didn't yield any fruitful matches, which is expected 
keeping in mind the problems and limitations of the EST 
database. Moreover, the likelihood of observing ESTs for 
alternative splice forms in a gene correlates with increasing 
number of ESTs for that gene; it is highest for highly 
expressed genes and virtually nil for low-abundance genes. 
This may be the most possible reason to explain why Yuji 
Khoara’s C. elegans expressed sequence tag (EST) database 
search for putative EST or cDNA support for possible 
occurrence of these new exons/transcripts failed. NCBI 
BLAST search was done to look for homology of these new 
spliced transcripts but no significant information could be 
obtained about the prospective similarity with other 
polypeptides. Consensuses splice signals that are not normally 
used as splice sites (known as “cryptic” splice sites) occur 
frequently in a given pre-mRNA. Generally, intronic 
sequences at splice junctions are highly conserved (99.24 
percent of introns have a “GT-AG” at their 5' and 3' ends, 
respectively) in almost all eukaryotic species. [26, 27] The 
presence of consensus sequences at the splice-donor /acceptor 
site is believed to be a structural feature that determines 
whether a specific splice site is used although these consensus 
sequences may not be always present. [27] Analysis of the 
exon-intron junction region of the newly predicted N-terminal 
exons of Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and 
Y95B8A.12f indicates structural conservation, as depicted 
(Table 1 under supplementary material). The presence of 
consensus sequences in the splice-donor /acceptor site 
provides the further confirmatory evidence for the existence 
of new N-terminal exons of Y95B8A.12c, Y95B8A.12d, 
Y95B8A.12e and Y95B8A.12f. After the failure in search for 
supporting EST or cDNA matches for our newly predicted 
transcripts, the next way to confirm our findings was to 
validate them using RT-PCR. 
 
Experimental validation of computationally identified new 
spliced transcripts 
RT-PCR amplification was used to validate the possible 
existence of new transcripts of Y95B8A.12 gene as predicted 
on the basis of computational analysis. Here, our aim was 
only to prove that what predictions we got from our 
computational analysis were genuine enough. So, we selected 
only 1 of the 2 (Y95B8A.12a) C. elegans Sequencing Group 
reported alternatively spliced transcripts of Y95B8A.12 gene 
for practical validation. Moreover, we were also unable to 
verify some of our predicted transcripts mainly Y95B8A.12e, 
Y95B8A.12f (arising form combination with Sanger’s 
prediction i.e. 2nd control Y95B8A.12b) as there was only 
around 20-30 bp difference in the transcripts, which was 
difficult to resolve on gel. For e.g. In Y95B8A.12a, the third 
exon (24 bp), is spliced out to give rise to another spliced 
transcript named as Y95B8A.12b (Figure 1). Briefly, for 
experimental confirmation of these spliced transcripts, total 
RNA, prepared from mixed-stage C. elegans, was reverse 
transcribed and the resulting single-stranded cDNA was PCR 
amplified (as detailed in materials and methods). Forward and 
Reverse primers used for the identification of splice 
transcripts were designed using a combination of 
bioinformatics tools and manual methods, so that they bind 
only to specific exon sequences. As a result, we would expect 
two reaction products, which are different in length if a splice 
event takes place. These exon specific primers were able to 
successfully validate the occurrence of the spliced transcripts 
by giving a band of anticipated size (Figure 2) when a 
particular primer pair specific to that particular exon was PCR 
amplified and products visualized on agarose gel, stained with 
ethidium bromide and photographed on a UV 
transilluminator. For transcripts of low abundance, for which 
the RT-PCR products could not be visualized after the 
procedure described above (as in case of predicted spliced 
transcripts Y95B8A.12d  Figure 2, lane 5) and for further 
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reaction, semi nested PCR was performed, in exactly same 
method as adopted above. So we were able to validate 
computational predictions for occurrence of new spliced 
transcripts of RhoGEF domain encoding Y95B8A.12 gene in 
C. elegans.  
 
The goal of our work was to use a novel bioinformatics 
approach capable of complementing the conventional 
methods of identifying spliced transcripts by providing 
efficient delineation of all possible putative gene transcripts. 
Our findings emphasize towards the urgent need to analyze 
genome data using a combination of bioinformatics tools, 
programmes in order to delineate all possible gene products 
and to estimate the true extent of alternative splicing in C. 
elegans genes. It may also encourage other researchers to take 
up similar exhaustive studies in several other finished 
genomes especially of humans with whom C. elegans share a 
close gene homology. Moreover, further studies in this 
direction could be taken up which would enhance our 
knowledge about the biological and functional significance of 
these spliced transcripts and their possible role in RhoGEF 
gene working and regulation. 
 
 
Figure 1: Showing the structure and organization of Y95B8A.12 gene with its predicted and already existing spliced 
transcripts: Organization of C. elegans RhoGEF domain containing gene Y95B8A.12 along with the predicted spliced 
transcripts: The exon, intron organization of the Y95B8A.12 gene, along with its existing spliced transcripts Y95B8A.12a, 
Y95B8A.12b and the newly predicted alternatively spliced transcripts Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and 
Y95B8A.12f.   Rectangular and square boxes indicate exons; dotted lines indicate the intronic and the untranslated regions, 
while solid joining lines show the splicing pattern of each spliced transcript. New exon of each Y95B8A.12a and Y95B8A.12b 
(control) and Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and Y95B8A.12f (predicted alternative exons) is shown by a different 
pattern in the box. Arrows (F1, F2, F3, R1 and R2) indicate the Primers designed specific for each computationally predicted 
exon 
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Figure 2: RT-PCR analysis of predicted spliced transcript of the Y95B8A.12 gene: RT-PCR analysis of predicted spliced 
transcript of the RhoGEF domain containing gene Y95B8A.12: RT-PCR amplification was used to determine the presence of 
transcripts, containing predicted exon, in total RNA prepared from mixed-stage C. elegans as described in the Materials and 
methods section. The migration of a series of size markers (M) is indicated on the right. RT-PCR products were obtained using a 
common reverse primer R1 (from exon 4) and exon specific forward primers representing each spliced transcripts. Lanes 1, 3, 5 
represent the product size (bp) of 468, 463 and 460 obtained using common reverse primer (R1) in combination with forward 
primers F1, F2 and F3 respectively. While lanes 2, 4, 6 represent the product size (bp) 406, 401 and 404  obtained after semi nested 
PCR using common reverse primer(R2 designed internal to exon 4) in combination with forward primers F1, F2 and F3 
respectively. Lane 5 is blank because no band was obtained in first PCR, while the corresponding transcript was validate by semi 
nested PCR (Lane 6) 
 
Comparative analysis of alternative splicing pattern of 
RhoGEF domain encoding genes in C. elegans and C. 
briggsae  
With the availability of C. briggsae whole-genome shotgun 
assembly (cb25.agp8), with an estimated coverage of 98 
percent of the whole genome it offers interesting research 
avenues to researchers engaged in parallel studies. As 
alternative
 splicing is a frequent and important aspect of gene 
regulation.
 It is of interest to compare the level and pattern of 
conservation of alternative
 splicing. These reasons prompted 
us to study alternative splicing pattern in C. elegans RhoGEF 
domain encoding orthologues gene in C. briggsae.  
 
C. elegans and C. briggsae share a similar number of protein-
coding genes (just under 20,000), with an estimate of 12,200 
orthologous genes. [28] C. elegans-C. briggsae orthologs are 
annotated in Worm base (http://www.wormbase.org/) 
according to the criteria of Stein et al.,  [28]  C. elegans 
orthologue of RhoGEF domain gene was identified from 
inspection of Wormbase  (http://www.wormbase.org/) and 
using Blastp function [29] at NCBI BLAST. Table 3 
(supplementary material) shows the comparison between 
alternative splicing patterns obtained in C. elegans-C. 
briggsae orthologues genes encoding RhoGEF domain. From 
Table 3 (supplementary material), it is clear that both the 
genes not only had almost same size of unusually large 5' 
untranslated region (UTR) (approximately 19 to 20 kb) but 
also a similar pattern of splicing. Secondly, the results 
obtained on computational analysis of this unusually large 
UTR region to look for possible alternatively spliced 
transcripts also produced similar results. As shown in this 
paper in case of computational analysis of about 19 kb of C. 
elegans RhoGEF domain encoding gene Y95B8A.12, we 
successfully verified the existence of two new spliced 
transcripts arising due to alternative splicing of Y95B8A.12 
pre-mRNA in 5'  untranslated region (Y95B8A.12c & 
Y95B8A.12d). Similarly on computational analysis of  about 
20kb of untranslated region of CBG05122 (orthologue gene 
of RhoGEF domain gene in C. elegans), we predicted the 
existence of three novel spliced transcripts arising due to 
alternative splicing of pre-mRNA in 5' untranslated region of 
CBG05122 having new N-terminal exons (N'-1a, N'-1b, N'-
1c). The splicing pattern obtained in the two organisms is 
remarkably similar, with almost same N-terminal exon size 
(Table 3 in supplementary material). Moreover, one of the 
predicted new N-terminal exons (N'-1a) has a marked 
similarity in the two organisms (1c & N'-1a) Figure 3(a) 
whereas this kind of amino acid similarity was not observed 
in the case of the other predicted spliced exons (1d & N'-1b) 
Figure 3(b). The possible reasons for which are still under 
investigation. Taking the above data and facts into 
consideration, we can easily say that N-terminal transcripts in 
both organisms arise due to alternative splicing of pre-mRNA 
in 5'  untranslated region. The almost similar pattern of 
alternative splicing event indicates towards the evolutionarily 
conserved nature of alternative splicing in the two closely 
related genomes and its possible role in evolution of the two 
species. It may be that patterns of alternative splicing
  are 
conserved at similar levels to genes and gene structures. Thus, 
it can easily be hypothesized that many, and probably most, 
alternative
 splicing events are conserved between C. elegans 
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Figure 3: Comparative sequence alignment analysis between the polypeptide sequences encoded by C. elegans and  C. 
briggsae orthologue genes (Y95B8A.12 and CBG05122): Sequence alignment picture of the polypeptide sequences encoded 
by alternative new N-terminal exons in C. elegans and C. briggsae orthologue genes (Y95B8A.12 and CBG05122) obtained 
using CLUSTAL W multiple sequence alignment. A grey highlight shows sequence similarity whereas no highlight means 
dissimilar residues 
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Supplementary material   
                                                                
Cosmid 
(Gene) 
5'-Exon-Intron boundary  3'-Intron-Exon boundary  Exons organization in 
transcripts 
Y95B8A.12a CAGAGgtaaa tccagCCAGA 1a-2-3-4--Last  (CN-1) 
Y95B8A.12b CAGAGgtaaa tccagCCAGA 1a-2-4----Last  (CN-2) 
Y95B8A.12c AGCCGgtaag tccagCCAGA 1c-2-3-4---Last  (PR-1) 
Y95B8A.12d CTGCGgtaag tccagCCAGA 1d-2-3-4---Last  (PR-2) 
Y95B8A.12e CTGCGgtaag tccagCCAGA 1d-2-4------Last  PR-3) 
Y95B8A.12f AGCCGgtaag tccagCCAGA 1c-2-4------Last  (PR-4) 
Table 1: Details of Exon-Intron boundary of Y95B8A.12 gene with its predicted and already existing spliced transcripts: 
Y95B8A.12a   and Y95B8A.12a are already existing spliced transcripts as per the C. elegans genome sequencing consortium 
marked as control (CN) while Y95B8A.12c, Y95B8A.12d, Y95B8A.12e and Y95B8A.12f represents the newly predicted spliced 
transcript marked as (PR). Consensus sequences at the   splice-donor /acceptor site (exon-intron-exon boundaries) are shown in 
bold. Nucleotides indicated in lower case are part of introns and in upper case are parts of exons at the exon-intron-exon 
boundaries 
 
Exon  Amino acid sequence N-terminal 
exon size 
Exons organization in 
transcripts 
1a MVDLQLFTPLIRYSEPEEGEPQTIHP 15  1a-2-3-4--Last  (CN-1) 
1b MVDLQLFTPLIRYSEPEEGEPQTIHP 15  1a-2-4----Last  (CN-2) 
1c MTSEAPALTLFHHIRGNQLIKPEEGEPQTIHP 21  1c-2-3-4--Last  (PR-1) 
1d MPLLYTARLQDRWRSPEEGEPQTIHP 15  1d-2-3-4--Last  (PR-2) 
1e MPLLYTARLQDRWRSPEEGEPQTIHP 15  1d-2-4----Last(PR-3) 
1f MTSEAPALTLFHHIRGNQLIKPEEGEPQTIHP 21  1c-2-4----Last(PR-4) 
Table 2: Amino acid sequences encoded by the predicted alternatively spliced N-terminal exons: Deduced amino acid sequences 
encoded by alternative first exons (shown in regular font) and the first part of the amino acid sequence encoded by exon 2 
(underlined) depending on the splicing pattern; number of amino acids encoded by the N-terminal exon is shown under N-
terminal exon size; 1a, 1b, 1c, 1d, 1e and 1f are the first exons of Y95B8A.12a and Y95B8A.12b (control); Y95B8A.12c, 
Y95B8A.12d, Y95B8A.12e and Y95B8A.12f (predictions) respectively; splicing pattern shows the manner in which the splicing 
occurs in both new predicted spliced transcripts (PR) and controls (CN) predicted by the C. elegans genome  sequencing 
consortium 
 
C. elegans gene (5'UTR (untranslated) region  approximately 19kb) 
Exon  Predicted Exon Size(amino 
acids) 
Exons organization in 
transcripts 
Amino acid Sequence encoded 
1c 21  1c-2-3-4----Last  MTSEAPALTLFHHIRGNQLIK 
1d 15  1d-2-3-4----Last  MPLLYTARLQDRWRS 
C. briggsae gene (5'UTR (untranslated) region  approximately 20kb) 
Exon  Predicted Exon Size(amino 
acids) 
Exons organization in 
transcripts 
Amino acid Sequence encoded 
N'-1a 21  N'1a-2-3-4----Last  MTSEAPALTLFHHLRGNQLIK 
N'-b 15  N'1b-2-3-4----Last  MFKPKFQEWTPMVRR 
N'-1c 30  N'1c---  3-4----Last  MGNFRRQSAIIGNRRKPSAIIDQLSVTVHD 
Table 3: A comparative view of alternative splicing pattern obtained in C. elegans and C. briggsae orthologue genes: 
Alternative splicing pattern obtained after Gene/Exon finder analysis on genomic DNA sequences of RhoGEF domain 
encoding gene from C. elegans (Y95B8A.12) and the corresponding orthologue gene sequence from C. briggsae (CBG05122) 
 